Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) Income towards Parent Company (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Income towards Parent Company for 8 consecutive years, with -$273.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Income towards Parent Company fell 22.63% to -$273.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$273.6 million, a 22.63% decrease, with the full-year FY2025 number at -$96.8 million, down 17.84% from a year prior.
  • Income towards Parent Company was -$273.6 million for Q4 2025 at Select Medical Holdings, up from -$277.8 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $196.2 million in Q2 2021 to a low of -$277.8 million in Q3 2025.
  • A 5-year average of -$38.7 million and a median of $29.6 million in 2023 define the central range for Income towards Parent Company.
  • Peak YoY movement for Income towards Parent Company: skyrocketed 568.35% in 2024, then crashed 806.33% in 2025.
  • Select Medical Holdings' Income towards Parent Company stood at $66.3 million in 2021, then tumbled by 313.8% to -$141.8 million in 2022, then fell by 29.1% to -$183.0 million in 2023, then fell by 21.9% to -$223.1 million in 2024, then decreased by 22.63% to -$273.6 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Income towards Parent Company are -$273.6 million (Q4 2025), -$277.8 million (Q3 2025), and -$265.8 million (Q2 2025).